Fevertree Drinks (LON:FEVR – Get Free Report)‘s stock had its “hold” rating reissued by stock analysts at Berenberg Bank in a research report issued to clients and investors on Monday, Digital Look reports. They presently have a GBX 780 price objective on the stock. Berenberg Bank’s price target would suggest a potential downside of 3.52% from the company’s previous close.
Separately, Jefferies Financial Group boosted their target price on Fevertree Drinks from GBX 1,080 to GBX 1,100 and gave the company a “buy” rating in a research report on Thursday, July 30th. One research analyst has rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of GBX 920.
Check Out Our Latest Stock Analysis on Fevertree Drinks
Fevertree Drinks Stock Up 3.8%
Fevertree Drinks (LON:FEVR – Get Free Report) last released its quarterly earnings results on Thursday, September 10th. The company reported GBX 9.50 EPS for the quarter. Fevertree Drinks had a return on equity of 11.88% and a net margin of 7.29%. On average, equities research analysts anticipate that Fevertree Drinks will post 38.3184173 EPS for the current fiscal year.
Fevertree Drinks Company Profile
Fevertree Drinks PLC, together with its subsidiaries, engages in the development and sale of premium mixer drinks in the United Kingdom, the United States, rest of Europe, and internationally. It offers Indian, Mediterranean, summer garden, elderflower, cucumber, damson and sloe berry, rhubarb and raspberry, aromatic, lemon, and Clementine tonic water products; pink grapefruit, soda water, raspberry and orange blossom, Mexican lime, Italian blood orange, white grape and apricot sodas; Silician, premium, and Madagascan cola and lemonades; British apple with garden mint, ginger, Sicilian lemonade, sparkling Mexican lime, Italian white grape and apricot, and light raspberry and rose lemonade softdrinks; and gingers.
Read More
- Five stocks we like better than Fevertree Drinks
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits
Receive News & Ratings for Fevertree Drinks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fevertree Drinks and related companies with MarketBeat.com's FREE daily email newsletter.
